Skip to main content

Table 4 Stepward forward regression analysis of lumbar BMD and metabolic parameters (A); stepward forward regression analysis of pyrilinks and BMD and metabolic variables (B)

From: Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

A: Dependent variable L-BMD

Beta

p

B: Dependent variable Pyrilinks

Beta

p

Age (years)

0,716

0,0002

   

Menopause duration (years)

−0,718

0,016

   

BMI (kg/m2)

0,279

0,0021

 

0,309

0,053

Waist circumference (cm)

   

−0,381

0,011

Triglycerides (mmol/L)

     

Insulin (mIU/L)

−0,273

0,009

   

PAI-1(U/l)

0,171

0,117

 

−0,274

0,0126

Pyrilinks (nMPD/mMc)

     

Osteocalcin (ng/ml)

−0,391

0,0001

   

L-BMD (g/cm2)

   

−0,319

0,0025

adjusted R2

0,408

0,00000

adjusted R2

0,251

0,0001

  1. PAI-1 plasminogen activator inhibitor 1, BMI body mass index, L-BMD lumbar bone mineral density